共 13 条
- [1] Adcock D.M., Moore G.W., Montalvao S.D., Kershaw G., Gosselin R.C., Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art, Semin Thromb Hemost, 49, 6, pp. 571-579, (2023)
- [2] Saadalla A., Seheult J., Pruthi R.K., Chen D., Von Willebrand factor multimer analysis and classification: a comprehensive review and updates, Semin Thromb Hemost, 49, 6, pp. 580-591, (2023)
- [3] Nogami K., Clot waveform analysis for monitoring hemostasis, Semin Thromb Hemost, 49, 6, pp. 592-599, (2023)
- [4] Larsen J.B., Hvas A.M., Hojbjerg J.A., Platelet function testing: update and future directions, Semin Thromb Hemost, 49, 6, pp. 600-608, (2023)
- [5] Bowyer A.E., Gosselin R.C., Factor VIII and factor IX activity measurements for haemophilia diagnosis and related treatments, Semin Thromb Hemost, 49, 6, pp. 609-620, (2023)
- [6] Warkentin T.E., Greinacher A., Laboratory testing for HIT and VITT antibodies: a narrative review, Semin Thromb Hemost, 49, 6, pp. 621-633, (2023)
- [7] Gardiner C., Echenagucia M., Gosselin R.C., The future of laboratory developed tests in hemostasis laboratories, Semin Thromb Hemost, 49, 6, pp. 634-640, (2023)
- [8] Marlar R.A., Laboratory evaluation of antithrombin, protein C and protein S, Semin Thromb Hemost, 49, 6, pp. 641-650, (2023)
- [9] Van Cott E.M., Orlando C., Moore G.W., Cooper P.C., Meijer P., Marlar R., Recommendations for clinical laboratory testing for antithrombin deficiency
- [10] communication from the SSC of the ISTH, J Thromb Haemost, 18, 1, pp. 17-22, (2020)